THC Tenet Healthcare Corporation New

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES                                                                                   
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5                       
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940                       

1. Name and Address of Reporting Person * Ramsey R. Scott	2. Issuer Name and Ticker or Trading Symbol TENET HEALTHCARE CORP [ THC ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director                    _____ 10% Owner __X__ Officer (give title below)    _____ Other (specify below) Principal Accounting Officer
(Last)          (First)          (Middle) 14201 DALLAS PARKWAY	3. Date of Earliest Transaction (MM/DD/YYYY) 2/26/2021
(Street) DALLAS, TX 75254 (City)        (State)        (Zip)	4. If Amendment, Date Original Filed (MM/DD/YYYY)	6. Individual or Joint/Group Filing (Check Applicable Line) _X _ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security (Instr. 3)	2. Trans. Date	2A. Deemed Execution Date, if any	3. Trans. Code (Instr. 8)		4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock (1)	2/26/2021		M		1798	A	(2)	9155	D
Common Stock	2/26/2021		F		493 (3)	D	$51.02	8662	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Trans. Date	3A. Deemed Execution Date, if any	4. Trans. Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
2020 February Restricted Stock Units	(1)	2/26/2021		M			1798	(1)	(1)	Common Stock (4)	1798	$0.00	3598	D

Explanation of Responses:
(1)	As previously reported, on February 26, 2020, the reporting person received a grant of 5,396 time-based restricted stock units that vest in one-third increments on each of the first, second and third anniversaries of the date of grant. The first anniversary occurred on February 26, 2021, resulting in the vesting and settlement of 1,798 shares of common stock, as shown in Table I. The remaining 3,598 restricted stock units are shown in Table II, of which 1,799 are scheduled to vest on each of February 26, 2022 and February 26, 2023.
(2)	Restricted stock units convert into common stock on a one-for-one basis.
(3)	Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3.
(4)	Time-based restricted stock units are settled in shares of the Company's common stock upon vesting.

Reporting Owners
Reporting Owner Name / Address	Relationships
	Director	10% Owner	Officer	Other
Ramsey R. Scott 14201 DALLAS PARKWAY DALLAS, TX 75254			Principal Accounting Officer

Signatures
Mark R. Jackson, as Attorney-in-Fact for R. Scott Ramsey		3/2/2021
**Signature of Reporting Person		Date